| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus, Human | 2 | 2025 | 234 | 0.910 |
Why?
|
| Genome, Viral | 1 | 2025 | 155 | 0.870 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2025 | 382 | 0.830 |
Why?
|
| Genome, Insect | 6 | 2020 | 81 | 0.820 |
Why?
|
| Caliciviridae Infections | 1 | 2025 | 289 | 0.750 |
Why?
|
| Norovirus | 1 | 2025 | 288 | 0.730 |
Why?
|
| Evolution, Molecular | 10 | 2020 | 657 | 0.710 |
Why?
|
| Lignin | 6 | 2013 | 19 | 0.660 |
Why?
|
| Phanerochaete | 4 | 2010 | 4 | 0.630 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2010 | 112 | 0.590 |
Why?
|
| Genomics | 13 | 2025 | 1624 | 0.580 |
Why?
|
| Phylogeny | 13 | 2025 | 707 | 0.560 |
Why?
|
| Genome, Fungal | 6 | 2013 | 33 | 0.540 |
Why?
|
| Mutation | 15 | 2025 | 6177 | 0.510 |
Why?
|
| Agaricus | 2 | 2013 | 2 | 0.500 |
Why?
|
| Sequence Analysis, DNA | 8 | 2021 | 1745 | 0.480 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2022 | 934 | 0.450 |
Why?
|
| Insect Proteins | 4 | 2020 | 99 | 0.450 |
Why?
|
| Genome | 6 | 2022 | 472 | 0.430 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2013 | 193 | 0.430 |
Why?
|
| Biomarkers, Tumor | 4 | 2025 | 1617 | 0.400 |
Why?
|
| Oxidoreductases | 2 | 2013 | 103 | 0.400 |
Why?
|
| Proteogenomics | 2 | 2025 | 108 | 0.380 |
Why?
|
| Genetic Variation | 5 | 2021 | 1557 | 0.370 |
Why?
|
| Gene Duplication | 4 | 2017 | 364 | 0.360 |
Why?
|
| Whole Genome Sequencing | 4 | 2022 | 357 | 0.350 |
Why?
|
| Germ-Line Mutation | 3 | 2020 | 372 | 0.350 |
Why?
|
| Biological Evolution | 4 | 2023 | 229 | 0.340 |
Why?
|
| Transcriptome | 6 | 2022 | 1162 | 0.340 |
Why?
|
| Pharmacogenetics | 2 | 2022 | 203 | 0.310 |
Why?
|
| Mixed Function Oxygenases | 2 | 2010 | 37 | 0.310 |
Why?
|
| Heteroptera | 2 | 2020 | 10 | 0.310 |
Why?
|
| Insecticide Resistance | 3 | 2020 | 30 | 0.310 |
Why?
|
| Host-Parasite Interactions | 3 | 2020 | 72 | 0.310 |
Why?
|
| Repressor Proteins | 4 | 2019 | 777 | 0.300 |
Why?
|
| Arthropods | 2 | 2020 | 22 | 0.290 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2025 | 825 | 0.280 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2021 | 207 | 0.270 |
Why?
|
| Xylella | 1 | 2006 | 1 | 0.250 |
Why?
|
| Plants | 1 | 2006 | 48 | 0.240 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2019 | 1276 | 0.240 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 380 | 0.240 |
Why?
|
| Multigene Family | 5 | 2020 | 289 | 0.230 |
Why?
|
| Oligonucleotide Probes | 1 | 2025 | 87 | 0.230 |
Why?
|
| Xenobiotics | 1 | 2005 | 27 | 0.230 |
Why?
|
| Genome, Bacterial | 1 | 2006 | 208 | 0.230 |
Why?
|
| Gene Transfer, Horizontal | 4 | 2020 | 45 | 0.230 |
Why?
|
| Organ Specificity | 1 | 2025 | 400 | 0.220 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 651 | 0.210 |
Why?
|
| Animals | 26 | 2023 | 34341 | 0.210 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 240 | 0.210 |
Why?
|
| Species Specificity | 5 | 2023 | 519 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 327 | 0.210 |
Why?
|
| Genetic Speciation | 2 | 2020 | 25 | 0.200 |
Why?
|
| Gene Flow | 1 | 2023 | 14 | 0.200 |
Why?
|
| Mosaicism | 1 | 2025 | 243 | 0.200 |
Why?
|
| Papio | 1 | 2023 | 58 | 0.200 |
Why?
|
| Viral Load | 1 | 2025 | 406 | 0.190 |
Why?
|
| Humans | 43 | 2025 | 131504 | 0.190 |
Why?
|
| Gastroenteritis | 1 | 2025 | 316 | 0.190 |
Why?
|
| Chromosomes, Mammalian | 1 | 2022 | 41 | 0.190 |
Why?
|
| Cell Proliferation | 3 | 2021 | 2464 | 0.190 |
Why?
|
| Mesocricetus | 1 | 2022 | 69 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2021 | 1001 | 0.180 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2022 | 34 | 0.180 |
Why?
|
| Herpesvirus 3, Equid | 1 | 2021 | 4 | 0.180 |
Why?
|
| Genotype | 2 | 2025 | 2655 | 0.180 |
Why?
|
| Hemorrhagic Disorders | 1 | 2021 | 23 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2015 | 600 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2020 | 3411 | 0.170 |
Why?
|
| Receptors, Odorant | 2 | 2020 | 36 | 0.170 |
Why?
|
| Pest Control, Biological | 2 | 2018 | 13 | 0.170 |
Why?
|
| Databases, Genetic | 3 | 2016 | 500 | 0.170 |
Why?
|
| Transplants | 1 | 2021 | 38 | 0.170 |
Why?
|
| Kidney Neoplasms | 2 | 2015 | 454 | 0.170 |
Why?
|
| Fungal Proteins | 2 | 2013 | 132 | 0.170 |
Why?
|
| Thysanoptera | 1 | 2020 | 4 | 0.170 |
Why?
|
| Life History Traits | 1 | 2020 | 5 | 0.170 |
Why?
|
| Elephants | 1 | 2021 | 46 | 0.170 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 2646 | 0.170 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2020 | 21 | 0.170 |
Why?
|
| Adaptation, Physiological | 3 | 2018 | 261 | 0.170 |
Why?
|
| Mutation Accumulation | 1 | 2020 | 2 | 0.160 |
Why?
|
| Hymenoptera | 1 | 2020 | 7 | 0.160 |
Why?
|
| GTP Phosphohydrolases | 2 | 2019 | 159 | 0.160 |
Why?
|
| Social Skills | 1 | 2020 | 16 | 0.160 |
Why?
|
| Paternal Age | 1 | 2020 | 16 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 2862 | 0.160 |
Why?
|
| Social Behavior | 2 | 2020 | 217 | 0.160 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2021 | 256 | 0.160 |
Why?
|
| Male | 25 | 2025 | 65158 | 0.160 |
Why?
|
| Female | 26 | 2025 | 71087 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2019 | 739 | 0.150 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 33 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2355 | 0.150 |
Why?
|
| DNA Methylation | 3 | 2021 | 1085 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 392 | 0.150 |
Why?
|
| Neurofibromin 1 | 1 | 2019 | 49 | 0.150 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 246 | 0.150 |
Why?
|
| Hemiptera | 1 | 2019 | 16 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2018 | 833 | 0.150 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 287 | 0.150 |
Why?
|
| Organ Transplantation | 1 | 2021 | 172 | 0.150 |
Why?
|
| DNA, Neoplasm | 2 | 2018 | 286 | 0.150 |
Why?
|
| Genetic Loci | 1 | 2020 | 359 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2020 | 228 | 0.150 |
Why?
|
| Insecticides | 2 | 2016 | 47 | 0.150 |
Why?
|
| Amino Acid Sequence | 4 | 2020 | 2562 | 0.140 |
Why?
|
| Genetic Markers | 1 | 2020 | 605 | 0.140 |
Why?
|
| Amphipoda | 1 | 2018 | 5 | 0.140 |
Why?
|
| Wasps | 1 | 2018 | 9 | 0.140 |
Why?
|
| Paraffin Embedding | 1 | 2018 | 41 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2018 | 131 | 0.140 |
Why?
|
| Heterotaxy Syndrome | 1 | 2019 | 64 | 0.140 |
Why?
|
| Isoptera | 1 | 2018 | 4 | 0.140 |
Why?
|
| Nucleic Acids | 1 | 2018 | 26 | 0.140 |
Why?
|
| Blattellidae | 1 | 2018 | 5 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 1 | 2021 | 434 | 0.140 |
Why?
|
| Cytochrome P-450 CYP2A6 | 1 | 2018 | 11 | 0.140 |
Why?
|
| Cluster Analysis | 4 | 2018 | 418 | 0.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 232 | 0.140 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 37 | 0.140 |
Why?
|
| Spiders | 1 | 2017 | 5 | 0.140 |
Why?
|
| Meningioma | 1 | 2019 | 135 | 0.130 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 137 | 0.130 |
Why?
|
| Forecasting | 1 | 2019 | 361 | 0.130 |
Why?
|
| Skin Neoplasms | 2 | 2015 | 904 | 0.130 |
Why?
|
| Prognosis | 7 | 2021 | 4951 | 0.130 |
Why?
|
| Feeding Behavior | 3 | 2020 | 724 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1541 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 116 | 0.130 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 205 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 2020 | 510 | 0.130 |
Why?
|
| Computational Biology | 3 | 2014 | 872 | 0.130 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 1297 | 0.130 |
Why?
|
| Nicotine | 1 | 2018 | 117 | 0.130 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 1831 | 0.130 |
Why?
|
| Coleoptera | 1 | 2016 | 11 | 0.130 |
Why?
|
| Ceratitis capitata | 1 | 2016 | 4 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 999 | 0.130 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 135 | 0.130 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 3614 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2017 | 233 | 0.120 |
Why?
|
| Genome, Human | 3 | 2021 | 1332 | 0.120 |
Why?
|
| Software | 1 | 2021 | 752 | 0.120 |
Why?
|
| Metabolome | 1 | 2019 | 329 | 0.120 |
Why?
|
| Ectoparasitic Infestations | 1 | 2016 | 7 | 0.120 |
Why?
|
| Death, Sudden | 1 | 2016 | 44 | 0.120 |
Why?
|
| Bedbugs | 1 | 2016 | 7 | 0.120 |
Why?
|
| Sezary Syndrome | 1 | 2015 | 14 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 152 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 27 | 0.120 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2015 | 21 | 0.120 |
Why?
|
| Diptera | 1 | 2015 | 20 | 0.120 |
Why?
|
| Biodiversity | 1 | 2015 | 77 | 0.110 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 92 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 1988 | 0.110 |
Why?
|
| Clonal Evolution | 1 | 2015 | 49 | 0.110 |
Why?
|
| DNA Copy Number Variations | 5 | 2019 | 1023 | 0.110 |
Why?
|
| Cyclin B | 1 | 2014 | 22 | 0.110 |
Why?
|
| Oncogene Fusion | 1 | 2014 | 26 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 437 | 0.110 |
Why?
|
| Exonucleases | 1 | 2014 | 27 | 0.110 |
Why?
|
| DNA Polymerase II | 1 | 2014 | 19 | 0.110 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2014 | 45 | 0.110 |
Why?
|
| Chromosomes | 1 | 2014 | 117 | 0.110 |
Why?
|
| Phenotype | 5 | 2025 | 4517 | 0.100 |
Why?
|
| Introduced Species | 3 | 2020 | 22 | 0.100 |
Why?
|
| Glioma | 1 | 2018 | 498 | 0.100 |
Why?
|
| Disease Progression | 5 | 2020 | 2205 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 93 | 0.100 |
Why?
|
| Biotransformation | 1 | 2013 | 53 | 0.100 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 156 | 0.100 |
Why?
|
| Snails | 1 | 2012 | 2 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 128 | 0.100 |
Why?
|
| Mutation, Missense | 2 | 2014 | 929 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2567 | 0.100 |
Why?
|
| Ecology | 1 | 2012 | 17 | 0.100 |
Why?
|
| Genome-Wide Association Study | 5 | 2020 | 1839 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 220 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2017 | 900 | 0.090 |
Why?
|
| DNA Replication | 1 | 2014 | 359 | 0.090 |
Why?
|
| Basidiomycota | 1 | 2012 | 11 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 849 | 0.090 |
Why?
|
| Adult | 11 | 2025 | 31666 | 0.090 |
Why?
|
| Sarcoma | 1 | 2014 | 210 | 0.090 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 803 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 2 | 2025 | 407 | 0.090 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2014 | 231 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 514 | 0.090 |
Why?
|
| Exome | 4 | 2018 | 1076 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1809 | 0.080 |
Why?
|
| Clone Cells | 2 | 2025 | 171 | 0.080 |
Why?
|
| Lung | 3 | 2025 | 1565 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 3672 | 0.080 |
Why?
|
| Drosophila | 1 | 2014 | 797 | 0.080 |
Why?
|
| A549 Cells | 2 | 2022 | 49 | 0.080 |
Why?
|
| Genetic Association Studies | 3 | 2019 | 838 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 731 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2016 | 1098 | 0.080 |
Why?
|
| Polyporales | 1 | 2009 | 1 | 0.080 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2010 | 79 | 0.080 |
Why?
|
| Middle Aged | 8 | 2025 | 28839 | 0.080 |
Why?
|
| Culture Media | 2 | 2010 | 175 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 723 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2010 | 436 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 758 | 0.070 |
Why?
|
| Base Sequence | 3 | 2022 | 2782 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 4037 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2010 | 785 | 0.070 |
Why?
|
| Gene Dosage | 2 | 2020 | 439 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1945 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 989 | 0.070 |
Why?
|
| Child | 9 | 2020 | 26239 | 0.070 |
Why?
|
| Neoplasms | 2 | 2020 | 2969 | 0.070 |
Why?
|
| Biopsy | 2 | 2021 | 1249 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 1894 | 0.060 |
Why?
|
| Plant Diseases | 1 | 2006 | 21 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 1788 | 0.060 |
Why?
|
| Fimbriae, Bacterial | 1 | 2006 | 40 | 0.060 |
Why?
|
| Young Adult | 5 | 2021 | 10092 | 0.060 |
Why?
|
| Gene Library | 2 | 2018 | 213 | 0.060 |
Why?
|
| Cell Line | 2 | 2022 | 2603 | 0.060 |
Why?
|
| Genes, Bacterial | 1 | 2006 | 217 | 0.060 |
Why?
|
| Oxidation-Reduction | 3 | 2012 | 442 | 0.060 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2005 | 5 | 0.060 |
Why?
|
| Reproduction | 2 | 2020 | 215 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2018 | 386 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1386 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2005 | 97 | 0.060 |
Why?
|
| Larva | 2 | 2016 | 252 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2005 | 54 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3452 | 0.060 |
Why?
|
| Trastuzumab | 1 | 2025 | 148 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2006 | 955 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 624 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2010 | 984 | 0.050 |
Why?
|
| Survival Rate | 2 | 2021 | 2149 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6916 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2025 | 262 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2005 | 313 | 0.050 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 19 | 0.050 |
Why?
|
| Aged | 5 | 2020 | 21238 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 258 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2015 | 420 | 0.050 |
Why?
|
| Carboplatin | 1 | 2022 | 80 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2005 | 751 | 0.050 |
Why?
|
| Infant | 4 | 2020 | 13300 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 46 | 0.050 |
Why?
|
| Animals, Zoo | 1 | 2021 | 17 | 0.040 |
Why?
|
| Oxygen | 1 | 2005 | 552 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2020 | 15047 | 0.040 |
Why?
|
| Age Factors | 2 | 2020 | 2870 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2021 | 125 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2023 | 338 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 96 | 0.040 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2020 | 5 | 0.040 |
Why?
|
| Food Chain | 1 | 2020 | 10 | 0.040 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2020 | 20 | 0.040 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 15 | 0.040 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 20 | 0.040 |
Why?
|
| Herbivory | 1 | 2020 | 7 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5120 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1516 | 0.040 |
Why?
|
| Genome Size | 1 | 2020 | 13 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 322 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2020 | 68 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 714 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 543 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2020 | 281 | 0.040 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2021 | 238 | 0.040 |
Why?
|
| Immunity | 1 | 2020 | 179 | 0.040 |
Why?
|
| Ecosystem | 1 | 2020 | 100 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2021 | 234 | 0.040 |
Why?
|
| CYS2-HIS2 Zinc Fingers | 1 | 2019 | 5 | 0.040 |
Why?
|
| DNA Transposable Elements | 1 | 2020 | 182 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2020 | 127 | 0.040 |
Why?
|
| Adolescent | 4 | 2021 | 20917 | 0.040 |
Why?
|
| Pigmentation | 1 | 2019 | 35 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 328 | 0.040 |
Why?
|
| United States | 3 | 2022 | 11794 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 228 | 0.040 |
Why?
|
| Peroxidases | 1 | 2019 | 30 | 0.040 |
Why?
|
| Virus Replication | 1 | 2022 | 597 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 2019 | 61 | 0.040 |
Why?
|
| Pets | 1 | 2018 | 19 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2020 | 496 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2015 | 4674 | 0.040 |
Why?
|
| Ecotoxicology | 1 | 2018 | 4 | 0.040 |
Why?
|
| Cytochrome P450 Family 4 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Sarcoma, Ewing | 1 | 2019 | 117 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2018 | 41 | 0.040 |
Why?
|
| Body Patterning | 1 | 2019 | 128 | 0.040 |
Why?
|
| Geologic Sediments | 1 | 2018 | 8 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 102 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 606 | 0.040 |
Why?
|
| Receptor, Notch2 | 1 | 2018 | 12 | 0.040 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2018 | 16 | 0.040 |
Why?
|
| Moths | 1 | 2018 | 17 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2018 | 22 | 0.040 |
Why?
|
| Wilms Tumor | 1 | 2019 | 120 | 0.040 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2018 | 36 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2018 | 66 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2020 | 344 | 0.030 |
Why?
|
| Tissue Banks | 1 | 2018 | 29 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 173 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 18473 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 411 | 0.030 |
Why?
|
| Crustacea | 1 | 2017 | 6 | 0.030 |
Why?
|
| Copepoda | 1 | 2017 | 7 | 0.030 |
Why?
|
| Smell | 1 | 2019 | 133 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 2017 | 13 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2021 | 502 | 0.030 |
Why?
|
| Aging | 1 | 2025 | 1264 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 588 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 204 | 0.030 |
Why?
|
| Synteny | 1 | 2017 | 69 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 105 | 0.030 |
Why?
|
| North America | 1 | 2018 | 256 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 828 | 0.030 |
Why?
|
| Insecta | 1 | 2017 | 51 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2017 | 73 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4684 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 598 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 174 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2020 | 1522 | 0.030 |
Why?
|
| Trees | 1 | 2016 | 20 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 318 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2019 | 225 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 1313 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2018 | 234 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2019 | 265 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 251 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2018 | 179 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 824 | 0.030 |
Why?
|
| Rhabdomyosarcoma | 1 | 2019 | 227 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1069 | 0.030 |
Why?
|
| Diagnosis | 1 | 2016 | 33 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 376 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2017 | 96 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 496 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 812 | 0.030 |
Why?
|
| Autopsy | 1 | 2016 | 119 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 665 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 428 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2015 | 20 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 750 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2015 | 36 | 0.030 |
Why?
|
| Access to Information | 1 | 2016 | 45 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 704 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 350 | 0.030 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2015 | 18 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1478 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 64 | 0.030 |
Why?
|
| Milk, Human | 1 | 2018 | 318 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 127 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 195 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 332 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 361 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 291 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 749 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 21 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1169 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 1 | 2015 | 35 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 1356 | 0.030 |
Why?
|
| CREB-Binding Protein | 1 | 2015 | 55 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 157 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 7 | 0.030 |
Why?
|
| Replication Origin | 1 | 2014 | 12 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1139 | 0.030 |
Why?
|
| RNA | 1 | 2018 | 531 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1861 | 0.030 |
Why?
|
| Microsatellite Instability | 1 | 2014 | 37 | 0.030 |
Why?
|
| Codon | 1 | 2014 | 95 | 0.030 |
Why?
|
| DNA Polymerase III | 1 | 2014 | 24 | 0.030 |
Why?
|
| Erdheim-Chester Disease | 1 | 2014 | 28 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2014 | 33 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 337 | 0.030 |
Why?
|
| Metagenome | 1 | 2015 | 143 | 0.030 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2014 | 32 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 158 | 0.030 |
Why?
|
| Workflow | 1 | 2015 | 139 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 62 | 0.030 |
Why?
|
| Histiocytosis, Sinus | 1 | 2014 | 34 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 100 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2019 | 557 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 166 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2014 | 141 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2014 | 157 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 173 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2016 | 195 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 3090 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 680 | 0.020 |
Why?
|
| ras Proteins | 1 | 2014 | 146 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2019 | 1344 | 0.020 |
Why?
|
| Reproduction, Asexual | 1 | 2012 | 3 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 323 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2014 | 426 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1236 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2012 | 80 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 305 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2019 | 1682 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 344 | 0.020 |
Why?
|
| DNA | 1 | 2018 | 1443 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 577 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1610 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2012 | 232 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2012 | 141 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 809 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 428 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2014 | 439 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5277 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2970 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 1087 | 0.020 |
Why?
|
| Biodegradation, Environmental | 1 | 2010 | 12 | 0.020 |
Why?
|
| Pichia | 1 | 2010 | 56 | 0.020 |
Why?
|
| Cytochromes b5 | 1 | 2010 | 3 | 0.020 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2010 | 4 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 865 | 0.020 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2010 | 4 | 0.020 |
Why?
|
| Catalysis | 1 | 2010 | 137 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 1795 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 286 | 0.020 |
Why?
|
| Nitrogen | 1 | 2010 | 122 | 0.020 |
Why?
|
| Carbon | 1 | 2010 | 93 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2019 | 2436 | 0.020 |
Why?
|
| Cellulases | 1 | 2009 | 2 | 0.020 |
Why?
|
| Wood | 1 | 2009 | 8 | 0.020 |
Why?
|
| Glycoside Hydrolases | 1 | 2009 | 17 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2010 | 81 | 0.020 |
Why?
|
| Enzymes | 1 | 2009 | 44 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 894 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6273 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10952 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7572 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3614 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 403 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1614 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2985 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 998 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1487 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1500 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1397 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 12936 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 8589 | 0.010 |
Why?
|